Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The aim of this book is to provide crisp information related to pathology, management and radiological/molecular imaging in breast carcinoma, along with detailed information on FDG PET-CT in breast cancer, normal variants, artefacts, pitfalls with atlas illustrations. The book is unique in providing quick reference to practice of PET/CT in breast cancer. The initial few chapters are related to the pathology and management of breast carcinoma to help understand the pathophysiology of breast cancer before going to the imaging. The chapter on imaging in breast cancer highlights the role of different imaging modalities for different indications to the reader. The last four chapters describe in detail the role, normal variants, artefacts and pitfalls of FDG PET/CT along with recent molecular imaging advances in breast cancer. Written by Pathology, Oncology, Radiology and Nuclear Medicine experts from different countries with enormous experience in breast cancer practice, the book addresses nuclear medicine physicians and radiologists, but it may be of interest to a wider medical community, including oncologists and radiotherapists. .

Breast Neoplasms --- Fluorodeoxyglucose F18 --- Positron Emission Tomography Computed Tomography. --- Molecular Imaging. --- diagnostic imaging. --- Imaging, Molecular --- CT PET --- CT PET Scan --- PET CT Scan --- PET-CT --- PET-CT Scan --- Positron Emission Tomography-Computed Tomography --- CT PET Scans --- CT Scan, PET --- CT Scans, PET --- PET CT Scans --- PET Scan, CT --- PET Scans, CT --- PET-CT Scans --- Scan, CT PET --- Scan, PET CT --- Scan, PET-CT --- Scans, CT PET --- Scans, PET CT --- Scans, PET-CT --- 18F-FDG --- Fluorine-18-fluorodeoxyglucose --- Fluorodeoxyglucose F 18 --- 18F Fluorodeoxyglucose --- 18FDG --- 2-Fluoro-2-deoxy-D-glucose --- 2-Fluoro-2-deoxyglucose --- Fludeoxyglucose F 18 --- 2 Fluoro 2 deoxy D glucose --- 2 Fluoro 2 deoxyglucose --- F 18, Fludeoxyglucose --- F 18, Fluorodeoxyglucose --- F18, Fluorodeoxyglucose --- Fluorine 18 fluorodeoxyglucose --- Fluorodeoxyglucose, 18F --- Nuclear medicine. --- Radiology. --- Oncology. --- Nuclear Medicine. --- Atomic medicine --- Radioisotopes in medicine --- Medical radiology --- Radioactive tracers --- Radioactivity --- Tumors --- Radiological physics --- Physics --- Radiation --- Physiological effect

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

"In the fast-changing age of precision medicine, PET/CT is increasingly important for accurate cancer staging and evaluation of treatment response. Fundamentals of Oncologic PET/CT, by Dr. Gary A. Ulaner, offers an organized, systematic introduction to reading and interpreting PET/CT studies, ideal for radiology and nuclear medicine residents, practicing radiologists, medical oncologists, and radiation oncologists. Synthesizing eight years' worth of cases and lectures from one of the largest cancer centers in the world, this title provides a real-world, practical approach, taking you through the body organ by organ as it explains how to integrate both the FDG PET and CT findings to best interpret each lesion"--Publisher's description.

Cancer --- Neoplasms --- Positron-Emission Tomography --- Tomography, X-Ray Computed --- Multimodal Imaging --- Fluorodeoxyglucose F18 --- Tomography. --- diagnosis. --- methods. --- therapeutic use. --- Oncology --- Tomography, Emission

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

FDG PET/CT has rapidly emerged as an invaluable combined imaging modality that can identify tumors on the basis of not only anatomical alterations but also metabolic activity, thus allowing the detection of lesions that would otherwise be too small to distinguish. This book, comprising a collection of images from oncology cases, is organized according to the role of FDG PET/CT in the evaluation and management of oncology patients, and only secondarily by organ or tumor entity. In this way, it reflects the issues that clinicians actually address in their daily practice, namely: identification of an unknown or unsuspected primary; determination of the extent of disease; evaluation of response to therapy; and surveillance after response, i.e., detection of recurrent disease. In total, 100 cases involving different primary tumors are presented to illustrate findings in these different circumstances. FDG PET/CT in Clinical Oncology will be of great value to all newcomers to this field, whether medical students, radiology, nuclear medicine, or oncology fellows, or practicing physicians.

Neoplasms -- Diagnosis. --- Radiopharmaceuticals. --- Single-photon emission computed tomography. --- Tomography. --- Tumors -- Tomography. --- Radiographic Image Enhancement --- Tomography, Emission-Computed --- Image Interpretation, Computer-Assisted --- Tomography, X-Ray --- Deoxyglucose --- Diseases --- Radionuclide Imaging --- Image Enhancement --- Diagnostic Imaging --- Tomography --- Deoxy Sugars --- Radiography --- Diagnostic Techniques and Procedures --- Photography --- Carbohydrates --- Diagnostic Techniques, Radioisotope --- Diagnosis --- Chemicals and Drugs --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Tomography, X-Ray Computed --- Positron-Emission Tomography --- Fluorodeoxyglucose F18 --- Neoplasms --- Medicine --- Health & Biological Sciences --- Oncology --- Radiology, MRI, Ultrasonography & Medical Physics --- Tumors --- Cancer --- Diagnosis. --- Tumours --- Medicine. --- Radiology. --- Oncology. --- Medicine & Public Health. --- Imaging / Radiology. --- Diagnostic Radiology. --- Pathology --- Cysts (Pathology) --- Radiology, Medical. --- Oncology  . --- Clinical radiology --- Radiology, Medical --- Radiology (Medicine) --- Medical physics --- Radiological physics --- Physics --- Radiation

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Although [18F]fluorodeoxyglucose (FDG) generally shows an excellent performance as a cancer-imaging agent when using PET-CT, there are some settings in which other radiopharmaceuticals offer advantages. Such non-FDG tracers are now gaining widespread acceptance not only in research but also in clinical practice, with the acquisition of promising results in the management of various cancers. This atlas, including about 500 high-quality images, is a user-friendly guide to PET-CT imaging beyond FDG. A wide range of tracers is covered, such as 18F- and 11C-choline, 11C-methionine, 18F-ethyl-L-tyrosine, 68Ga-DOTA-NOC, 11C-acetate, 11C-thymidine, and 18F-DOPA. Throughout, the emphasis is on image interpretation, with guidance on the recognition of normal, benign, and malignant uptake and clear instruction on learning points and pitfalls. This book is a companion to the editors’ recently published Atlas of PET-CT, which focuses exclusively on the use of FDG. It is designed to serve as a reference text for both nuclear physicians and radiologists, and will also be of great benefit to radiographers, technologists, and nuclear medicine and radiology residents.

Positron-Emission Tomography -- Atlases. --- Tip Faku ̈ltesi Ku ̈tu ̈phanesi. --- Tomography, Emission -- Atlases. --- Tomography, Emission. --- Tomography, Emission-Computed -- Atlases. --- Tomography, Emission --- Positron-Emission Tomography --- Radiopharmaceuticals --- Tomography, Emission-Computed --- Atlases --- Fluorodeoxyglucose F18 --- Image Enhancement --- Indicators and Reagents --- Radionuclide Imaging --- Tomography --- Deoxyglucose --- Publication Formats --- Image Interpretation, Computer-Assisted --- Diagnostic Imaging --- Laboratory Chemicals --- Photography --- Publication Characteristics --- Deoxy Sugars --- Diagnostic Techniques, Radioisotope --- Carbohydrates --- Diagnostic Techniques and Procedures --- Specialty Uses of Chemicals --- Chemical Actions and Uses --- Diagnosis --- Chemicals and Drugs --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Radiology, MRI, Ultrasonography & Medical Physics --- Oncology --- Medicine --- Health & Biological Sciences --- Cancer --- Radiopharmaceutical agents --- Medicine. --- Radiology. --- Nuclear medicine. --- Oncology. --- Medicine & Public Health. --- Nuclear Medicine. --- Imaging / Radiology. --- Medical radiology --- Pharmacology --- Radiology, Medical. --- Oncology  . --- Tumors --- Clinical radiology --- Radiology, Medical --- Radiology (Medicine) --- Medical physics --- Atomic medicine --- Radioisotopes in medicine --- Radioactive tracers --- Radioactivity --- Physiological effect --- Radiological physics --- Physics --- Radiation --- Tıp Fakültesi Kütüphanesi

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Pancreatic neoplasms include different pathological entities with variable biological behavior and different treatment modalities. Surgery and adjuvant therapy are the cornerstones of the therapeutic approach; however, even after radical resection, the majority of patients experience disease recurrence and the prognosis of pancreatic cancer remains dismal. A multimodal therapeutic approach, based on a combination of neoadjuvant therapy, chemotherapy, radiotherapy, immunotherapy and surgery, appears fundamental to improving the outcomes. This Special Issue of the Journal of Clinical Medicine, entitled “Recent Advances in Pancreatic Neoplasms”, focuses on possible new strategies to treat pancreatic neoplasms.

Medicine --- Oncology --- PIWI proteins --- PIWIL3 --- PIWIL4 --- pancreatic cancer --- EMT --- chemoresistance --- motility --- HNF4A --- survival --- pancreatic neuroendocrine neoplasm --- primary pancreatic carcinoid --- serotonin-secreting pancreatic tumour --- serotonin-producing pancreatic tumour --- neoadjuvant chemotherapy --- response --- carbohydrate antigen 19-9 --- fluorodeoxyglucose --- pancreatectomy --- positron emission tomography --- prognosis --- standardized uptake value --- Pancreatic ductal adenocarcinoma --- microRNAs --- pancreatic fistula --- pancreatic neoplasm --- renal cell carcinoma --- pancreatic neoplasms --- PET-CT scan --- pancreatic ductal adenocarcinoma --- pancreatic cancer prognosis --- completion total pancreatectomy --- pooled analysis --- recurrent pancreatic cancer --- repeated pancreatectomy --- pancreas --- neuropathy --- taxanes --- biomarker --- C-reactive protein to albumin ratio --- inflammation --- intraductal papillary mucinous neoplasm --- modified Glasgow prognostic score --- neutrophyl lymphocite ratio --- platelet-to-lymphocyte ratio --- robotic pancreatic surgery --- pancreato-gastrostomy --- low muscle mass --- sarcopenia --- pancreatic adenocarcinoma --- pancreatic surgery --- body composition --- n/a